us sanofi aventis regeneron contract 111009
On the homepage
Vikings
Out There
Pardon Board
Petters
Sanofi-Aventis, Regeneron Pharmaceuticals extend development deal through 2017
Print this story
E-mail this story
Save to del.icio.us
Share on Facebook
Share on Digg
Minnesota business by the numbers
See Minnesota's top earning companies, CEOs and non-profits
More from Business
NEW YORK - Sanofi-Aventis and Regeneron Pharmaceuticals Inc. said Tuesday they expanded an existing development partnership to run through 2017.
Initially, the partnership signed in 2007 was set to end in 2012.
Under the expanded deal, the companies plan on advancing up to five antibodies into clinical development each year, with Sanofi-Aventis funding up to $160 million annually for Regeneron research until the end of 2017 — up from prior funding levels of $100 million annually.
The companies have so far pushed four potential drugs into clinical development, aimed at conditions ranging from rheumatoid arthritis and pain, to advanced malignancies.
Shares of Sanofi-Aventis, headquartered in Paris, fell 2 cents to close at $37.89.
Shares of Regeneron, headquartered in Tarrytown, N.Y., rose 33 cents, or 2.1 percent, to reach $16.13 in after-hours trading after gaining 12 cents to close at $15.80 during the regular trading session.
Recent Business stories
More consumers make credit card payments on time in 3Q, pay off debt in summer months - November 10, 2009
More consumers make credit card payments on time in 3Q, pay off debt in summer months - Consumers got more serious about paying down their credit card debt this summer, a time when deliquencies usually go up. More
- Holiday gift: Amazon-Wal-Mart price war
- Record 2.1M dropside cribs recalled
- Verdict? Petters jurors back at it today
- Economy's rebound not as strong as first thought
- A man with a plan to get jobless working stiffs back to work
- Stores jump the gun to get jump on competition
- Medtronic reports higher second-quarter earnings
Blog: Patent Pending
Lights out at U energy conference. Irony police notified.
Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.
Comment on this story | Be the first to comment | Hide reader comments